Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK and Tres Cantos Open Lab Foundation announce additional £5m funding for open innovation research in diseases impacting the developing world
- Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe
- ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
Tweets from GSK
-
GSK @GSK
Today, we announce our new partnership with @USPharmacopeia and @USAID to increase availability of a life-saving antiseptic for newborns in developing countries.
about 1 hour ago -
GSK @GSK
As one of the few companies researching treatments and vaccines for #HIV, #TB and #malaria – all three @WHO priority infectious diseases – we are proud to be at #UNGA helping to take on the #GlobalGoals #SDGs #BFPNYC
about 2 hours ago -
GSK @GSK
We’re talking to @FightPoverty today at #BFPNYC, sharing how our science is helping address the biggest health challenges affecting children and young people in developing countries #MondayMotivation #UNGA #SDGs
about 5 hours ago
